OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AKE59

AKE.PA

Specialty ChemicalsVerified

AKE.PA has a debt-to-equity ratio of 0.67, indicating a moderate level of leverage, and a current ratio of 2.13, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -42 million EUR, and its operating cash flow is 997 million EUR, which may signal pressure on liquidity despite a relatively strong cash and equivalents position of 1.3 billion EUR. In terms of profitability, AKE.PA's return on equity is 0.92%, and its return on assets is 0.44%, both of which are below the typical thresholds for strong performance in the specialty chemicals industry. The company's operating income of 288 million EUR and net income of 63 million EUR suggest a relatively narrow margin, which may be a concern in a competitive industry where cost efficiency is critical. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification may increase exposure to sector-specific risks, such as raw material price volatility or regulatory changes affecting the chemical industry. Geographically, the company's exposure is not specified, but the absence of geographic diversification could pose a risk if demand in its primary market declines. AKE.PA's growth trajectory appears to be modest, with no specific revenue growth rates provided in the available data. The company's capital expenditure of -668 million EUR indicates a significant investment in long-term assets, which may support future growth but could also strain short-term liquidity if not offset by sufficient cash flow. Analysts have assigned a mean price target of 63.27 EUR, with a median of 62.00 EUR, suggesting a generally neutral outlook with a range of 50.00 EUR to 83.00 EUR. The company's risk profile includes a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint, which could affect the company's ability to meet short-term obligations or fund operations without external financing. No dilution sources are identified in the available data, and the dilution risk is assessed as low, indicating that the company is not expected to issue additional shares in the near term. Recent events, such as filings and transcripts, are not detailed in the available data, but the company's financial performance and analyst estimates suggest a stable but not particularly dynamic business environment. The company's performance is in line with the broader industry trends, with no significant deviations in the available financial metrics.

30-day price · AKE-0.60 (-1.0%)
Low$58.50High$66.00Close$60.65As of28 May, 00:00 UTC
Profile
CompanyAKE.PA
TickerAKE.PA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. AKE.PA is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.

Classification. AKE.PA is classified under the Basic Materials economic sector, within the Chemicals business sector and the Specialty Chemicals industry, with a classification confidence of 0.92.

AKE.PA has a debt-to-equity ratio of 0.67, indicating a moderate level of leverage, and a current ratio of 2.13, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -42 million EUR, and its operating cash flow is 997 million EUR, which may signal pressure on liquidity despite a relatively strong cash and equivalents position of 1.3 billion EUR. In terms of profitability, AKE.PA's return on equity is 0.92%, and its return on assets is 0.44%, both of which are below the typical thresholds for strong performance in the specialty chemicals industry. The company's operating income of 288 million EUR and net income of 63 million EUR suggest a relatively narrow margin, which may be a concern in a competitive industry where cost efficiency is critical. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification may increase exposure to sector-specific risks, such as raw material price volatility or regulatory changes affecting the chemical industry. Geographically, the company's exposure is not specified, but the absence of geographic diversification could pose a risk if demand in its primary market declines. AKE.PA's growth trajectory appears to be modest, with no specific revenue growth rates provided in the available data. The company's capital expenditure of -668 million EUR indicates a significant investment in long-term assets, which may support future growth but could also strain short-term liquidity if not offset by sufficient cash flow. Analysts have assigned a mean price target of 63.27 EUR, with a median of 62.00 EUR, suggesting a generally neutral outlook with a range of 50.00 EUR to 83.00 EUR. The company's risk profile includes a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint, which could affect the company's ability to meet short-term obligations or fund operations without external financing. No dilution sources are identified in the available data, and the dilution risk is assessed as low, indicating that the company is not expected to issue additional shares in the near term. Recent events, such as filings and transcripts, are not detailed in the available data, but the company's financial performance and analyst estimates suggest a stable but not particularly dynamic business environment. The company's performance is in line with the broader industry trends, with no significant deviations in the available financial metrics.
Key takeaways
  • AKE.PA has a moderate debt load and sufficient short-term liquidity, but its free cash flow is negative, which may affect its ability to fund operations without external financing.
  • The company's profitability metrics, such as return on equity and return on assets, are below typical thresholds for strong performance in the specialty chemicals industry.
  • AKE.PA's business is concentrated in a single segment, which increases exposure to sector-specific risks and may limit diversification benefits.
  • Analysts have a generally neutral outlook on the company, with a mean price target of 63.27 EUR and a range of 50.00 EUR to 83.00 EUR.
  • The company's capital expenditure is significant, which may support future growth but could also strain short-term liquidity if not offset by sufficient cash flow.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$9.07B
Gross profit$1.61B
Operating income$288.0M
Net income$63.0M
R&D
SG&A
D&A
SBC
Operating cash flow$997.0M
CapEx-$668.0M
Free cash flow-$42.0M
Total assets$14.24B
Total liabilities$7.40B
Total equity$6.84B
Cash & equivalents$1.30B
Long-term debt$4.56B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.84B
Net cash-$3.25B
Current ratio2.1
Debt/Equity0.7
ROA0.4%
ROE0.9%
Cash conversion15.8%
CapEx/Revenue-7.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricAKEActivity
Op margin3.2%5.5% medp25 -0.0% · p75 10.8%below median
Net margin0.7%4.1% medp25 0.1% · p75 8.8%below median
Gross margin17.8%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-7.4%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity67.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target63.27 EUR
Median price target62.00 EUR
High price target83.00 EUR
Low price target50.00 EUR
Mean recommendation2.50 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count6.00
Hold count7.00
Sell count1.00
Strong-sell count1.00
Mean EPS estimate4.68 EUR
Last actual EPS4.32 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 22:21 UTC#72717660
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:30 UTCJob: b7ba0b75